Value Bridge — WESTCHESTER MEDICAL CENTER
Current $42M → Target $78M (+$36.1M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$41.6M
Current EBITDA
$77.7M
Target EBITDA
+$36.1M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$8.2M
Payer Mix Optimization
$19.6M
Cost to Collect Reduction
$6.5M
Clean Claim Improvement
$4.9M
Volume & Rate Growth
$32.7M
What This Means
The 7-lever model projects a 87% EBITDA uplift from $42M to $78M. The highest-impact lever is Volume & Rate Growth at $13.1M probability-weighted.
IC talking point: "We see $36M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $397M in equity value creation."